These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25546696)

  • 21. Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.
    Kutyifa V; Kosztin A; Klein HU; Biton Y; Nagy VK; Solomon SD; McNitt S; Zareba W; Goldenberg I; Roka A; Moss AJ; Merkely B; Singh JP
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1410-1420. PubMed ID: 30466845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The European CRT Survey: 1 year (9-15 months) follow-up results.
    Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K;
    Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT.
    Biton Y; Kutyifa V; Zareba W; Klein HU; Solomon SD; McNitt S; Polonsky B; Moss AJ; Goldenberg I
    Heart Fail Rev; 2015 Sep; 20(5):535-43. PubMed ID: 26216033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Approach to cardiac resyncronization therapy.
    Dobreanu D; Dagres N; Svendsen JH; Marinskis G; Bongiorni MG; Blomström-Lundqvist C
    Europace; 2012 Sep; 14(9):1359-62. PubMed ID: 22930718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of serum albumin level and clinical outcomes among heart failure patients receiving cardiac resynchronization therapy].
    Yang SW; Liu ZM; Mi JR; Liu SY; Ding LG; Chen KP; Hua W; Zhang S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):204-208. PubMed ID: 28316176
    [No Abstract]   [Full Text] [Related]  

  • 27. Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival.
    Manne M; Rickard J; Varma N; Chung MK; Tchou P
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):970-7. PubMed ID: 23718783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapy.
    Stabile G; Pepi P; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Rapacciuolo A; Arena G; Marini M; Pieragnoli P; Badolati S; Savarese G; Maglia G; Iuliano A; Botto GL; Malacrida M; Bertaglia E
    Heart Rhythm; 2018 Nov; 15(11):1675-1682. PubMed ID: 29665405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The stricter criteria for Class I CRT indication suggested by the 2016 ESC Guidelines reliably exclude patients with a worse prognosis in comparison with the 2013 ESC indication criteria.
    Bertaglia E; Reggiani A; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Arena G; Marini M; Ricciardi G; Badolati S; Spotti A; Solimene F; Ferraro A; Migliore F; Botto GL; Malacrida M; Stabile G
    Int J Cardiol; 2018 Dec; 273():162-167. PubMed ID: 30217421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac Resynchronization Therapy: US Trends and Disparities in Utilization and Outcomes.
    Sridhar AR; Yarlagadda V; Parasa S; Reddy YM; Patel D; Lakkireddy D; Wilkoff BL; Dawn B
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003108. PubMed ID: 26921376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).
    Lee AY; Moss AJ; Ruwald MH; Kutyifa V; McNitt S; Polonsky B; Zareba W; Ruwald AC
    Am J Cardiol; 2015 May; 115(10):1423-7. PubMed ID: 25817576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood disorders and outcome in patients receiving cardiac resynchronization therapy.
    Shalaby A; Brumberg G; El-Saed A; Saba S
    Pacing Clin Electrophysiol; 2012 Mar; 35(3):294-301. PubMed ID: 22229659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W
    Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT).
    Goldenberg I; Moss AJ; Hall WJ; Foster E; Goldberger JJ; Santucci P; Shinn T; Solomon S; Steinberg JS; Wilber D; Barsheshet A; McNitt S; Zareba W; Klein H;
    Circulation; 2011 Oct; 124(14):1527-36. PubMed ID: 21900084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomical factors involved in difficult cardiac resynchronization therapy procedure: a non-invasive study using dual-source 64-multi-slice computed tomography.
    Da Costa A; Gate-Martinet A; Rouffiange P; Cerisier A; Nadrouss A; Bisch L; Romeyer-Bouchard C; Isaaz K
    Europace; 2012 Jun; 14(6):833-40. PubMed ID: 22117034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
    Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
    J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
    Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.